References
- Krain LS. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol 1975;111:241–5.
- Person CM. Polymyositis and dermatomyositis. In: McCarty DJ, editor. Arthritis and allied conditions. 9th ed. Philadelphia: Lea and Ferbiger; 1979. p. 742–61.
- Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344–7.
- Nawata Y, Kurasawa K, Takabayashi K, Mike S, Watanabe N, Hiragiri M, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporin. J Ftheumatol 1999;26:1527–33.
- Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (der-matomyositis sine myositis): presentation of six new cases and review of the literature. J Am Acad Dermatol 1991;24:959–66.
- Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol 1993;100:S124–7.
- Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 1995;108:311–15.
- Hamada H, Kohno N, Yokoyama A, Hirasawa Y, Hiwada K, Sakatani M, et al. KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromized hosts. Intern Med 1998;37:307–10.
- Kavanagh GM, Ross JS, Black MM. Dermatomyositis treated with cyclosporin. J R Soc Med 1991;84:306.
- Lueck CJ, Trend P, Swash M. Cyclosporin in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psychiatry 1991;54:1007–8.
- Kohno N, Koizumi S, Awaya S. New serum indicator of interstitial pneumonitis activity: sialylated carbohydrate antigen KL-6. Chest 1989;96: 68–73.
- Kitamura S, Hiwada K, Kobayashi J, Kohno N, Kawai T, Satou A, et al. Use of the ED046 kit to analyze serum KL-6 in patients with pneumonitis (in Japanese, abstract English). Nihon Kyobu Shikkan Gakkai Zasshi 1996;34:639–45.
- Kohno N, Awaya Y, Oyama T. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148: 637–42.
- Yokoyama A, Kohno N, Kondo K, Ueda S, Hirasawa Y, Watanabe K, et al. Comparative evaluation of sialylated carbohy-drate antigen, KL-6, CA19-9, and SLX as serum markers for inter-stitial pneumonia. Respirology 1998;3:199–202.